Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for ultrasonic interventional therapy of pelvic abscess and preparation method of pharmaceutical composition

A technology for interventional treatment and pelvic abscess, which is applied in the directions of drug combination, drug formulation, drug delivery, etc., can solve the problem that the effect of antibiotic treatment is not completely satisfactory, and achieve the effect of improving drug efficacy, high safety, and enhancing immunity

Inactive Publication Date: 2016-09-28
杨洪青
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

That is to say, the effect of antibiotic treatment is not completely satisfactory, and there are many defects in surgical treatment.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] The pharmaceutical composition for ultrasonic interventional treatment of pelvic abscess is mainly composed of the following components by weight: 3 parts of artificial bezoar, 2 parts of acetylsalicylic acid, 1 part of solanine, 0.01 part of metronidazole, blood root 0.2 parts of alkali, 0.5 parts of chelerythrine, 0.8 parts of forsythol, 0.3 parts of hyperoside, 0.2 parts of isorhamnetin, 0.5 parts of houttuyniatin, 0.6 parts of terpene, 0.1 part of kaempferol , 0.1 part of resveratrol.

[0019] The preparation method of the pharmaceutical composition for ultrasonic interventional treatment of pelvic abscess is as follows:

[0020] (1) Take artificial bezoar, acetylsalicylic acid, solanine, metronidazole, sanguinarine, chelerythrine, forsythol, hyperin, isorhamnetin of said weight portion , houttuyniatin, untethered terpene, kaempferol, resveratrol, spare;

[0021] (2) the acetylsalicylic acid, metronidazole, sanguinarine, chelerythrine, forsythol, hyperoside, houtt...

Embodiment 2

[0025] The pharmaceutical composition for ultrasonic interventional treatment of pelvic abscess is mainly composed of the following components by weight: 4 parts of artificial bezoar, 2.5 parts of acetylsalicylic acid, 1.1 parts of solanine, 0.012 parts of metronidazole, blood root 0.4 parts of alkali, 1 part of chelerythrine, 1.2 parts of forsythol, 0.5 parts of hyperoside, 0.3 parts of isorhamnetin, 1 part of houttuyniatin, 0.7 parts of untethered terpene, 0.2 parts of kaempferol , 0.2 parts of resveratrol.

[0026] The preparation method of the pharmaceutical composition for ultrasonic interventional treatment of pelvic abscess is as follows:

[0027] (1) Take artificial bezoar, acetylsalicylic acid, solanine, metronidazole, sanguinarine, chelerythrine, forsythol, hyperin, isorhamnetin of said weight portion , houttuyniatin, untethered terpene, kaempferol, resveratrol, spare;

[0028] (2) the acetylsalicylic acid, metronidazole, sanguinarine, chelerythrine, forsythol, hyp...

Embodiment 3

[0032] The pharmaceutical composition for ultrasonic interventional treatment of pelvic abscess mainly consists of the following components by weight: 5.5 parts of artificial bezoar, 3.5 parts of acetylsalicylic acid, 1.25 parts of solanine, 0.02 parts of metronidazole, blood root 0.7 parts of alkali, 1.25 parts of chelerythrine, 1.9 parts of forsythol, 0.9 parts of hyperoside, 0.5 parts of isorhamnetin, 2.25 parts of houttuyonin, 0.8 parts of untethered terpene, 0.3 parts of kaempferol , 0.55 parts of resveratrol.

[0033] The preparation method of the pharmaceutical composition for ultrasonic interventional treatment of pelvic abscess is as follows:

[0034] (1) Take artificial bezoar, acetylsalicylic acid, solanine, metronidazole, sanguinarine, chelerythrine, forsythol, hyperin, isorhamnetin of said weight portion , houttuyniatin, untethered terpene, kaempferol, resveratrol, spare;

[0035](2) the acetylsalicylic acid, metronidazole, sanguinarine, chelerythrine, forsythol...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Apertureaaaaaaaaaa
Login to View More

Abstract

The invention discloses a pharmaceutical composition for ultrasonic interventional therapy of pelvic abscess and a preparation method of the pharmaceutical composition. The pharmaceutical composition mainly consists of the following components in parts by weight: 3-8 parts of calculus bovis factitius, 2-5 parts of acetylsalicylic acid, 1-1.5 parts of solamargine, 0.01-0.03 parts of metronidazole, 0.2-1.2 parts of sanguinarine, 0.5-2 parts of chelerythrine, 0.8-3 parts of forsythol, 0.3-1.5 parts of hyperoside, 0.2-0.8 parts of isorhamnetin, 0.5-4 parts of houttuynin, 0.6-1 part of friedelin, 0.1-0.5 parts of kaempferol and 0.1-1 part of resveratrol. The pharmaceutical composition disclosed by the invention is a medicine which is prepared on the basis of inventor's researches for a long time in accordance with own clinical experiences; the pharmaceutical composition has functions of clearing heat and resisting bacteria, activating blood circulation to remove pus, suppressing inflammation and alleviating pains, and the pharmaceutical composition is capable of effectively resisting infection of various bacteria and boosting immunity; in combination with the ultrasonic interventional therapy, fine needle aspiration is conducted under the guidance of B ultrasound so as to directly reach a focus region, and the medicine is injected; therefore, the curative effect of the medicine is enhanced; and the pharmaceutical composition, on the pelvic abscess, is significant in curative effect, high in safety and free from obvious side effects.

Description

technical field [0001] The invention relates to the technical field of ultrasonic interventional therapy drugs, in particular to a pharmaceutical composition for ultrasonic interventional therapy of pelvic abscess and a preparation method thereof. Background technique [0002] Pelvic abscess is a serious pelvic inflammatory disease, mainly from the infection of anaerobic bacteria, and the pus has fecal odor and bubbles. At present, antibiotics are mainly used for treatment. The principles of antibiotic treatment are: empiric, broad-spectrum, timely and individualized. It is reasonable to choose antibiotics based on drug susceptibility tests, but antibiotics are usually given before laboratory results are obtained. Therefore, initial treatment is often based on empirical selection of antibiotics, broad-spectrum antibiotics and combination drugs. Surgical treatment is required when antibiotic control is not satisfactory. Transabdominal surgery or laparoscopic surgery can be s...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K35/413A61K9/00A61K49/22A61P15/00A61P31/04A61P37/04A61K31/706A61K31/7048A61K31/616A61K31/56A61K31/4741A61K31/4164A61K31/352A61K31/185A61K31/05
CPCA61K9/0009A61K31/05A61K31/185A61K31/352A61K31/4164A61K31/4741A61K31/56A61K31/616A61K31/7048A61K31/706A61K35/413A61K49/22A61K2300/00
Inventor 杨洪青赵伟陆东霞
Owner 杨洪青
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products